Breast Neoplasms: all 12,820 studies
Page 118 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.
- Delayed-Immediate Breast ReconstructionCompletedNCT00473122Phase 2
- Efficacy Study of an Educational Program for Decision Support for Breast CancerCompletedNCT00473096Not applicable
- Phase I Oral mTOR Inhibitor RAD001 in Combo w/ Capecitabine for Metastatic BreastTerminatedNCT00473005Phase 1
- Bevacizumab and Abraxane as Second-line Therapy in Triple Negative Metastatic Breast CancerCompletedNCT00472693Phase 2
- A Biological Sample Collection Protocol of Women With and Without Breast CancerCompletedNCT00472589
- Development of a Questionnaire to Evaluate Patient Expectations for Breast Reconstruction in Women With Breast Cancer or Other ConditionsCompletedNCT00471601Not applicable
- OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid TumorsCompletedNCT00471432Phase 1
- A Study Of Docetaxel Or Docetaxel Plus PF-3512676 To Treat Patients With Advanced Breast Cancer.WithdrawnNCT00471159Phase 2
- Carboplatin and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Breast CancerTerminatedNCT00470249Phase 2
- Effect of a Low-Calorie Diet and/or Exercise Program on Risk Factors for Developing Breast Cancer in Overweight or Obese Postmenopausal WomenCompletedNCT00470119Not applicable
- Risk Communication Within Mexican-American FamiliesCompletedNCT00469339
- Component and Couple Analysis of Cancer CommunicationsCompletedNCT00468741Not applicable
- Phase Ⅱ Clinical Study of R435 (Bevacizumab) in Combination With Paclitaxel in Patients With Inoperable Metastatic Breast CancerCompletedNCT00467012Phase 2
- Psychological and Social Factors and Risk Chronic Pain After Surgery in Women With Breast CancerWithdrawnNCT00466830
- Efficacy of RAD001 in Breast Cancer Patients With Bone MetastasesStatus unknownNCT00466102Phase 2
- Liposomal Doxorubicin (Lipo-Dox) in Patients With Brain Metastasis From Breast CancerTerminatedNCT00465673Phase 2
- Preoperative Estetrol in Breast CancerCompletedNCT00464516Phase 2
- Lifestyle Intervention Study in Adjuvant Treatment of Early Breast CancerCompletedNCT00463489Not applicable
- Genes That Affect Disease Progression in Women With Newly Diagnosed or Metastatic Breast CancerStatus unknownNCT00463034
- GW572016 In Patients With Advanced Or Metastatic Breast CancerCompletedNCT00462956Phase 1
- A Mammography FastTrack Program in Increasing the Number of Women Undergoing Breast Cancer ScreeningCompletedNCT00462891Not applicable
- Effect of Advertisements on Treatment Compliance in Women With Breast CancerCompletedNCT00462410Not applicable
- Trial of Tomotherapy in Breast CancerStatus unknownNCT00459628Not applicable
- Comparison of Two Schedules of Zoledronic Acid in Treating Patients With Breast Cancer That Has Spread to the BoneTerminatedNCT00458796Not applicable
- Long-Term Effect of Adolescent Diet on Hormones and Breast Cancer Risk in Women Previously Enrolled in the Dietary Intervention Study in ChildrenCompletedNCT00458588
- Dynamic Breast MRI in Assessing Locally Advanced Breast CancerCompletedNCT00455273
- INST 0514C- Biologic Correlative Study: Trial of GW572016 in HER2 Overexpressing Breast Cancer PatientsWithdrawnNCT00455039Phase 1/2
- Study With Docetaxel, Carboplatin and Herceptin Versus Vinorelbine and Herceptin in HER-2 (+) Metastatic Breast Cancer PatientsTerminatedNCT00453635Phase 2
- Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer Progressing After Endocrine TreatmentTerminatedNCT00452140Phase 2
- Phase I/II Study of Neoadjuvant Lapatinib in Breast CancerCompletedNCT00450892Phase 1/2
- Pazopanib in Treating Patients With Newly Diagnosed or Locally and/or Regionally Recurrent Breast Cancer That Can Be Removed By SurgeryTerminatedNCT00450879Phase 1
- Gemcitabine + Carboplatin in Breast CancerCompletedNCT00450762Phase 2
- Vinflunine and Capecitabine in Treating Patients With Previously Treated Metastatic Breast CancerWithdrawnNCT00450515Phase 2
- Computer-Aided Breast Cancer Detection in Women Undergoing Screening MammographyCompletedNCT00450359Not applicable
- EndoTAG-1 in Triple Receptor Negative Breast Cancer PatientsCompletedNCT00448305Phase 2
- Intensified IAA With PBPC Support in Breast Tumors With Evidence of a HRDTerminatedNCT00448266Phase 2/3
- Blood Sample Collection and Health Information Collection From Patients With Invasive Breast Cancer and Their Brothers and SistersStatus unknownNCT00445562
- Changes in Breast Density and Breast Cancer Risk in Women With Breast Cancer and in Healthy WomenCompletedNCT00445445
- Bevacizumab and Doxorubicin Hydrochloride Liposome in Treating Women With Locally Recurrent or Metastatic Breast CancerCompletedNCT00445406Phase 2
- Study of Gemcitabine and Herceptin Versus Xeloda and Herceptin in HER-2 (+) Metastatic Breast Cancer PatientsTerminatedNCT00440622Phase 3
- Effects of Hands-on-Healing vs. Touch for Fatigued Breast Cancer SurvivorsCompletedNCT00440089Phase 2/3
- Injection Methods in Finding the Sentinel Lymph Node During Lymphatic Mapping and Sentinel Lymph Node Biopsy in Patients With Invasive Breast CancerCompletedNCT00438477Not applicable
- Neoadjuvant Hormonal Treatment of Postmenopausal Women Who Have Operable Breast CancerCompletedNCT00437853Not applicable
- Antiestrogen vs Aromatase Inhibitor After Adjuvant Chemotherapy for Breast CancerTerminatedNCT00437359Phase 2
- Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast CancerStatus unknownNCT00436709Not applicable
- Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic CancerCompletedNCT00436410Early Phase 1
- Vaccine Therapy With Sargramostim (GM-CSF) in Treating Patients With Her-2 Positive Stage III-IV Breast Cancer or Ovarian CancerCompletedNCT00436254Phase 1
- Capecitabine Plus Radiotherapy for Local Relapse Breast Cancer With Negative Her2 TumoursTerminatedNCT00434941Phase 2
- Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone MetastasesCompletedNCT00434447Phase 4
- 5-Fluorouracil Combined With CoFactor (5-10 Methylenetetrahydrofolate) in Treating Advanced Breast Cancer PatientsStatus unknownNCT00434369Phase 2
- CETRA: Neoadjuvant Caelyx and Trastuzumab in Her-2 Positive Breast CancerWithdrawnNCT00434031Phase 2
- Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid TumorsCompletedNCT00433602
- Genetic Testing or Clinical Assessment in Determining the Need for Chemotherapy in Women With Breast Cancer That Involves No More Than 3 Lymph NodesCompletedNCT00433589Phase 3
- Combination Chemotherapy With or Without Fluorouracil and/or Pegfilgrastim in Treating Women With Node-Positive Breast CancerActive, not recruitingNCT00433420Phase 3
- T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid TumorsCompletedNCT00433407Not applicable
- Vinorelbine (Oral) Plus Trastuzumab for 1st-line Treatment of HER2/Neu Overexpressing Breast CancerCompletedNCT00433095Phase 2
- Randomized Phase II Study of Epirubicin vs Caelyx in Pretreated Metastatic Breast CancerTerminatedNCT00431795Phase 2
- VinCaT: Vinorelbine, Carboplatin and Trastuzumab in Advanced Her-2 Positive Breast CancerStatus unknownNCT00431704Phase 2
- Vinorelbine and Gemcitabine Versus Capecitabine in Pretreated Metastatic Breast CancerCompletedNCT00431106Phase 3
- Randomized Phase III Trial Comparing Sequential Administration of FE75C Followed by Docetaxel Versus Paclitaxel as Adjuvant Chemotherapy in Axillary Lymph Node (+) Breast CancerCompletedNCT00431080Phase 3
- Vinorelbine Plus (+) Trastuzumab vs Docetaxel Plus (+) Trastuzumab as 1 Line Treatment for HER2 Positive (+) Metastatic Breast CancerStatus unknownNCT00430001Phase 3
- Study of Ductal Lavage in Women at High Risk for Breast CancerCompletedNCT00429988
- Randomized Phase III Trial With Docetaxel Plus Epirubicine Versus Docetaxel Plus Capecitabine for Metastatic Breast CancerCompletedNCT00429871Phase 3
- Preserving Function in Breast Cancer PatientsCompletedNCT00429286
- Randomized Trial With Trastuzumab Versus Observation in Breast Cancer PatientsCompletedNCT00429247Phase 2
- A Feasibility Study With Iressa in Resistant Cytokeratin-Positive Tumor Cells Circulating in the Blood of Women With Breast CancerCompletedNCT00428896Phase 2
- Delayed Adjuvant Herceptin® Treatment in Patients With HER-2 Positive Breast CancerTerminatedNCT00427427Phase 2
- Goserelin in Preventing Early Menopause in Premenopausal Women Undergoing Chemotherapy for Stage I, Stage II, or Stage III Breast CancerCompletedNCT00427245Phase 3
- Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast CancerCompletedNCT00426530Phase 1
- Evaluation of Group CBT Programme With Breast Cancer PatientsStatus unknownNCT00426335
- Treatment of Hot Flushes in Breast Cancer Patients With AcupunctureCompletedNCT00425776Phase 1
- Study of Zoledronic Acid Administered Monthly Versus Every 3 Months in Multiple Myeloma and Breast Cancer Patients Who Were Treated With Zoledronic Acid the Prior YearCompletedNCT00424983Phase 1
- Epirubicin and Docetaxel Combination (ET) or Epirubicin Followed by Docetaxel (E/T) for Node Negative (N0) High Risk Breast Cancer PatientsCompletedNCT00424606Phase 3
- Doxorubicin and Cyclophosphamide in Treating Older Women With Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By SurgeryCompletedNCT00424203Phase 2
- Lapatinib and Tamoxifen in Treating Patients With Advanced or Metastatic Breast CancerCompletedNCT00424164Phase 1
- Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.CompletedNCT00423254Phase 1
- Bone Geometry and Muscle Density Changes in Postmenopausal Women and Breast Cancer Patients Prescribed AnastrozoleCompletedNCT00421447
- Bone Response in Metastatic Breast Cancer Involving BonesCompletedNCT00420433
- Use of Hair to Diagnose the Presence of Breast CancerStatus unknownNCT00419900Phase 1/2
- Acupuncture in the Management of Post Operative Symptoms in Breast Cancer PatientsCompletedNCT00419822Not applicable
- Use of Hair to Diagnose Breast CancerStatus unknownNCT00419679Phase 1/2
- Proteomic Analysis of HLA Complex in Solid Cancers: Breast, Ovary, Colon, Rectum, Stomach, and PancreasStatus unknownNCT00419627
- Genetic Counseling in African American WomenCompletedNCT00419510Not applicable
- Body Image and Psychosocial Functioning in Women With Breast Cancer: Can We Fix What We've Broken?CompletedNCT00418444Not applicable
- Accelerated Partial Breast Irradiation for Early Breast CancerCompletedNCT00418210Not applicable
- Sentinel Lymph Node Technique in Multifocal Breast CancerCompletedNCT00417495Phase 2
- Individualized Risk-Based Education in Promoting Breast Cancer Screening in Healthy WomenCompletedNCT00416975Not applicable
- Psychosocial Support in Treating Women With Recurrent Breast Cancer or Stage I, Stage II, or Stage IV Breast CancerCompletedNCT00416780Not applicable
- Genetic Counseling in Women at Risk for BRCA1 or BRCA2 MutationsCompletedNCT00416754Not applicable
- Nausea or Vomiting in Patients Who Are Receiving Chemotherapy for Breast Cancer or Lung CancerCompletedNCT00416689
- Effect of Fluvastatin on Biomarkers in Women Who Are Undergoing Surgery for Ductal Carcinoma In Situ or Stage I Breast CancerCompletedNCT00416403Phase 2
- Clinical Trial of SAHA in Patients With Breast CancerStatus unknownNCT00416130Phase 1/2
- Docetaxel Followed by Capecitabine Versus Concomitant Docetaxel/Capecitabine for Early Stage Breast CancerStatus unknownNCT00415285Phase 2
- National Screening in Denmark With MR Versus Mammography and Ultrasound of Women With BRCA1 or BRCA2 MutationsStatus unknownNCT00413491Phase 4
- CNF2024 (BIIB021) HER2- (QD) HER2+ (BIW w/Herceptin) PK/PD StudyCompletedNCT00412412Phase 1
- HOBOE: A Phase 3 Study of Adjuvant Triptorelin and Tamoxifen, Letrozole, or Letrozole and Zoledronic Acid in Premenopausal Patients With Breast Cancer.Active, not recruitingNCT00412022Phase 3
- Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell TransplantCompletedNCT00410657Phase 2
- Placebo-controlled Evaluation of Cocculine® Efficacy in the Management of Nausea After Chemotherapy in Breast Cancer.CompletedNCT00409071Phase 3
- Livial Intervention Following Breast Cancer; Efficacy, Recurrence and Tolerability Endpoints (LIBERATE)(COMPLETED)(P05885)CompletedNCT00408863Phase 3
- Using Test of SCM for Detection Breast CancerStatus unknownNCT00407706